MarketVIEW: Acne vaccines

  • September 2012
  • -
  • VacZine Analytics Group Of Assay Advantage Ltd

Acne vulgaris is a common skin condition which is estimated to affect 80% of people at some point between 11 and 30 years of age. The condition ranges from mild to severe with latter more likely to cause scarring and psychological impact such as depression, loss of self esteem and in extreme cases, suicidal ideation. Acne is responsible for a significant number of yearly physician office visits and direct costs for treatments which range from OTC lotions to prescription based antibiotics/retinoids.

An acne vaccine targeting the main causative bacterium P.acnes could have wide utility if it prevents inflammatory outbreaks in individuals suffering from acne. Indeed, the major vaccine manufacturer Sanofi Pasteur has already announced interest in this concept (University of San Diego collaboration) confirming its potential attractiveness.

This MarketVIEW product is a comprehensive commercial opportunity assessment which forecasts the potential of acne vaccines (value/volume) to 2030 in the Western region. The product examines different uptake scenarios of the vaccine in severe and non-severe patient groups at different age range(s). Detailed coverage of latest acne epidemiology is included, also a focus on current treatment pathways, costs and the need for a novel vaccine approach. This product is an essential component of any new internal exercise assessing the potential of new acne vaccines.

THIS PRODUCT IS A SUMMARY PRESENTATION + MODEL

Table Of Contents

Contents - Executive presentation (MS PowerPoint based)

Title Page
Contents
Author’s notes
Executive Summary
Commercial model: key outputs
Acne vaccine: available market ($ 000s) to 2030 (severe patients)
Acne vaccine: predicted volume (doses 000s) to 2030 (severe patients)
Acne vaccine: available market ($ 000s) to 2030 per country (severe patients)
Acne vaccine: available market ($ 000s) to 2030 (all patients)
Acne vaccine: predicted volume (doses 000s) to 2030 (all patients)
Acne vaccine: available market ($ 000s) to 2030 (BASE SCENARIO)
Acne vaccine: predicted volume (doses 000s) to 2030 (BASE SCENARIO)
Acne Vulgaris: disease background and epidemiology
Acne: brief disease background
Acne: clinical types
Acne: global epidemiology
Acne: adult acne statistics
Acne: impact of the disease
Acne: treatment pathway
Acne: treatment overview
Acne: treatment options
Acne: effectiveness of treatment in mild and moderate cases
Acne: effectiveness of treatment in severe cases
Acne: cost of treatment
Acne: cost of treatment in the US
Acne vaccine; target product profile (TPP)
The role of an acne vaccine
Current status of the vaccine
Pipeline summary
Addressable vaccine populations
Acne vaccine forecast model
Forecast vaccine population flow
Acne vaccine: target product profile
Commercial model assumptions
Detailed commercial model assumptions by country (LO uptake)
Detailed commercial model assumptions by country (BASE uptake)
Detailed commercial model assumptions by country (HI uptake)
Acne vaccine: other target populations
Bibliography
Disclaimer
About VacZine Analytics

PAGES: ~50 MS PowerPoint slides, fully referenced/sourced. Available in .pdf form

Contents - Vaccine demand model(s) (MS Excel-based)

Note: further models can be included with differing vaccine price scenarios

Title page
TOTAL CHARTS (ALL PATIENTS)
TOTAL CHARTS (severe only)
BASE (severe versus non-severe)
CHARTS - VAL HIGH (severe only)
CHARTS - VAL BASE (severe only)
CHARTS - VAL LOW (severe only)
CHARTS - VOL HIGH (severe only)
CHARTS - VOL BASE (severe only)
CHARTS - VOL LOW (severe only)
VALUE SUMMARY (severe only)
VOLUME SUMMARY (severe only)
VALUE SUMMARY (ALL PATIENTS)
VOLUME SUMMARY (ALL PATIENTS)
Country worksheets =>>
US
CANADA
UK
FRANCE
GERMANY
ITALY
SPAIN
AUSTRALIA
JAPAN
Assumptions

Worksheets = 44 per model

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Shadi

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023

  • $ 9 995
  • Industry report
  • March 2014
  • by Global Data

PharmaPoint: Migraine - Global Drug Forecast and Market Analysis to 2023 Summary The migraine market is saturated with generic drugs, and the remaining branded products already on the market are expected ...

Antibiotics: Technologies and Global Markets

Antibiotics: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • May 2014
  • by BCC Research

Use this report to: - Identify the major market trends and the factors driving or inhibiting the growth of the global pharmaceutical antibiotics market and its various submarkets. - Learn about developments ...

Antifungal Drugs : Technologies and Global Markets

Antifungal Drugs : Technologies and Global Markets

  • $ 6 650
  • Industry report
  • June 2014
  • by BCC Research

This report aims to determine the current status of the global human antifungal market and assess its growth potential over the five-year period from 2013 through 2018. It covers approved human therapeutics ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.